Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse-Reference-Cited by-同舟云学术

Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse

Published:2018-10-03 Issue:1 Volume:20 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Lanzillotta Marco,Della-Torre Emanuel,Milani Raffaella,Bozzolo Enrica,Bozzalla-Cassione Emanuele,Rovati Lucrezia,Arcidiacono Paolo Giorgio,Partelli Stefano,Falconi Massimo,Ciceri Fabio,Dagna Lorenzo

Funder

Fondazione Italiana per la Ricerca sull’Artrite

Italian Association for Cancer Research (AIRC)/Cariplo Foundation

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-018-1718-5.pdf

Reference28 articles.

1. Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181:191–206.

2. Campochiaro C, Ramirez GA, Bozzolo EP, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45:135–45.

3. Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688–99.

4. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460–71.

5. Culver EL, Sadler R, Bateman AC, et al. Increases in IgE, eosinophils, and mast cells can be used in diagnosis and to predict relapse of IgG4-related disease. Clin Gastroenterol Hepatol. 2017;15:1444–52.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IgG4-related disease as an unexpected cause of hemoptysis;Rare and Interstitial Lung Diseases;2025

2. B-cell depletion works in IgG4-related disease. What else?;European Journal of Internal Medicine;2024-09

3. B cell depletion after treatment with rituximab predicts relapse of IgG4-related disease;Rheumatology;2024-05-23

4. Increased prevalence of malignancies in patients with IgG4-related disease: implications for clinical care;Rheumatology;2024-05-02

5. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies;Frontiers in Oncology;2024-03-25